Philips’ Insights on the EU AI Act’s Impact on Medical Innovation
Philips’ Chief Innovation Officer, Shez Partovi, emphasizes the need for the EU AI Act to ensure patient safety while fostering innovation in the AI medical device sector. He expresses concerns that overlapping regulatory requirements could hinder the growth of smaller companies and urges for a balance that promotes trust without stifling innovation.